- BBS Pharmaceuticals Contact
- contact@bbspharmaceuticals.com
BBS Pharmaceuticals News
[display-posts include_excerpt=”true” excerpt_length=”20″ image_size=”thumbnail” wrapper=”div” wrapper_class=”display-posts-listing image-left”]
June 18, 2020
It has been a busy and productive start of the second quarter here at BBS Pharmaceuticals. We had the honour toto welcome local Member of Hammond, […]
June 11, 2020
It has been a busy and incredibly productive start of the week here at BBS as we are entering the second half of the year. This […]
April 23, 2020
Michael Kromwyk has been appointed Head of Sales and Marketing at BBS Pharmaceuticals with responsibility for brand and marketing programs, sales strategy, growing product sales, partnering […]
April 14, 2020
As various phases of legalisation come intoto effect in different parts of Australia, the country’s cannabis market is expected toto break through the barrier of US$1.5 […]
March 27, 2020
The Australian Senate Committee has revealed their recommendations from the inquiry ‘Current barriers toto patient access toto medicinal cannabis in Australia’. In its 118-page long document, […]
February 14, 2020
Don’t bring others down! Message from BBS Pharmaceuticals’ CEO, John Dagas regarding the medicinal cannabis industry. “The start of 2020 has seen a number of medicinal […]
January 24, 2020
“Medicinal cannabis can be the healthcare success stotory of our lifetime,” says Hugh Hempel, In this moving talk, he discusses how medicinal cannabis has enriched the […]
January 17, 2020
“It’s the teams that make histotory… Alone, we can do so little; totogether we can do so much.” BBS was born one night as two friends, […]
January 17, 2020
BBS Pharmaceuticals featured in Health Europa Medical Cannabis Network’s latest issue…